Podcast

Learning the Basics of Immunotherapy

Author(s):

Kristie L. Kahl

In this week’s episode of “CURE® Talks Cancer,” we delve into immunotherapy breakthroughs and how a new series of patient summits can help individuals learn more.

Breakthroughs in immunotherapy continue to advance in the treatment landscape for cancer, but patients do not always understand what these therapies are and how they work.

This year, the Cancer Research Institute (CRI) is hosting five Immunotherapy Patient Summits for patients, caregivers and advocates to meet, get valuable information from health care experts and learn more about how new breakthroughs in immunotherapy are changing standards of care for all cancers.

For this week’s episode of “CURE® Talks Cancer,” we spoke with a patient who underwent chimeric antigen receptor (CAR)-T cell therapy in a clinical trial, as well as CRI’s CEO, who offered more information about what these summits consist of and why they’re so helpful.

To learn more, visit:

https://www.cancerresearch.org/?rel=0?rel=0

https://www.cancerresearch.org/?rel=0?rel=0patients/immunotherapy-patient-summit-series

Newsletter

Stay up to date on cancer updates, research and education

Subscribe Now!
Related Videos
Related Content
doctor in white coat holding out hand with the word "immunotherapy" floating in front of it
September 2nd 2024

Postsurgical Keytruda Has Little Impact on Quality of Life in Melanoma

Ashley Chan
Health-related quality of life among patients with stage 3 melanoma was not significantly affected after receiving postsurgical Keytruda or placebo.
cancer horizons logo: a white microphone on a navy blue background
March 11th 2024

Oncology Approvals, Psychological Outcomes for Survivors and an Ovarian Cancer Vaccine

Alex Biese Brielle Benyon
Last week we saw some FDA approvals come through, as well as research that explored the psychosocial outcomes of individuals who survived pediatric rhabdosarcoma.
FDA developing story
November 1st 2023

FDA Approves Keytruda Plus Chemo for Locally Advanced, Metastatic Biliary Tract Cancer

Brielle Benyon
The Food and Drug Administration approved Keytruda plus chemotherapy for patients with locally advanced unresectable or metastatic biliary tract cancer.
cancer horizons podcast logo: a white microphone on a blue background
March 4th 2024

Cannabis Talks During Cancer, Cardiometabolic Comorbidities and Current Research

Alex Biese Brielle Benyon
In addition to a breakthrough therapy designation for a lung cancer drug, this week we’ll be talking a lot about additional side effects and health conditions that may come with a cancer diagnosis, and how to manage them.
clinician in a white coat holding his hand up with the word "immunothearpy"
August 14th 2023

Immunotherapy Shows Promise in Penile Cancer Subset

Brielle Benyon
Certain patients with penile squamous cell carcinoma responded to therapy with an immune checkpoint inhibitor, according to recent research.
Cancer vaccine medication treatment to heal the disease | Image credit: © Ursula Page - © stock.adobe.com
April 17th 2023

Cancer Vaccine Combo a ‘Potential Major Breakthrough’ in Skin Cancer

Gina Mauro
The addition of a personalized cancer vaccine to Keytruda led to a 44% reduction in the risk of death or recurrence in certain patients with melanoma.